<DOC>
	<DOC>NCT00687063</DOC>
	<brief_summary>The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.</brief_summary>
	<brief_title>Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Any subject with type 2 diabetes Subjects with a hypersensitivity to insulin detemir or any of its excipient Children below 6 years Subjects who are pregnant, lactating or planning to become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>